Treatment Updates
  • 1
  • 2
  • 3
  • 4
  • 5

Latest Programs

10 of 48 Shown
  • In this online educational program, expert faculty explore what will be needed to achieve HCV elimination in the United States. Choose from 6 short foundational videos, 3 ClinicalThought commentaries, and a module with accompanying slideset that details answers to commonly asked questions on the management of key at-risk populations.

    Achieving HCV Elimination in the United States: Progress and Next Steps

    In this online educational program, expert faculty explore what will be needed to achieve HCV elimination in the United States. Choose from 6 short foundational videos, 3 ClinicalThought commentaries, and a module with accompanying slideset that details answers to commonly asked questions on the management of key at-risk populations.
    Date Posted: 10/18/2017
  • Learn patient-specific HBV treatment recommendations from our panel of experts using this Interactive Decision Support Tool, Virtual Presentation, and expert-authored commentaries.

    Evolving Options for HBV Therapy: Navigating the New Treatment Landscape

    Learn patient-specific HBV treatment recommendations from our panel of experts using this Interactive Decision Support Tool, Virtual Presentation, and expert-authored commentaries.
    Date Posted: 10/10/2017
  • Customized for primary care clinicians, this program reviews best practices on screening appropriate patients for HCV, evaluating HCV-infected patients, counseling patients on treatment, and identifying when to refer patients to a specialist.

    Hepatitis C: Simplified Management From Screening to Cure

    Customized for primary care clinicians, this program reviews best practices on screening appropriate patients for HCV, evaluating HCV-infected patients, counseling patients on treatment, and identifying when to refer patients to a specialist.
    Date Posted: 9/26/2017
  • David Kaplan, MD, MSc, and Tamar Taddei, MD, developed this slideset to highlight the latest data on best practices for the care of patients with HCC across the disease spectrum and to address specific issues unique to treating veterans.

    Latest Developments in the Treatment of Hepatocellular Carcinoma: A Grand Round Series for VHA Clinicians

    David Kaplan, MD, MSc, and Tamar Taddei, MD, developed this slideset to highlight the latest data on best practices for the care of patients with HCC across the disease spectrum and to address specific issues unique to treating veterans.
    Date Posted: 9/19/2017
  • In this on-demand Webcast and downloadable slideset, CCO’s expert faculty explore optimal care for patients for HCC, including current systemic therapy options and individualizing treatment based on patient and disease characteristics, as well as promising investigational targeted therapies.

    Hepatocellular Carcinoma: Clinical Insights on Expanding Systemic Treatment Options

    In this on-demand Webcast and downloadable slideset, CCO’s expert faculty explore optimal care for patients for HCC, including current systemic therapy options and individualizing treatment based on patient and disease characteristics, as well as promising investigational targeted therapies.
    Date Posted: 6/7/2017
  • In this CME-certified educational activity, an expert panel comprising Jordi Bruix, MD; Yelena Y. Janjigian , MD; John L. Marshall, MD; and Neeta Somaiah, MD, discuss the most recent clinical data informing the optimal use of VEGF-targeted therapies in the care of patients with advanced CRC, HCC, gastric/GEJ cancer, and GIST.

    Reviewing the Role of VEGF-Targeting Agents in the Treatment of GI Cancers

    In this CME-certified educational activity, an expert panel comprising Jordi Bruix, MD; Yelena Y. Janjigian , MD; John L. Marshall, MD; and Neeta Somaiah, MD, discuss the most recent clinical data informing the optimal use of VEGF-targeted therapies in the care of patients with advanced CRC, HCC, gastric/GEJ cancer, and GIST.
    Date Posted: 3/13/2017
  • In these 2 modules from <I>in</I>Practice, experts review optimal strategies, key considerations, and recent guidelines on current management of HBV and HCV infection. In addition, each module includes concise summaries of key clinical data and implications of those data for clinical practice.

    Clinical Resources From inPractice Hepatology

    In these 2 modules from inPractice, experts review optimal strategies, key considerations, and recent guidelines on current management of HBV and HCV infection. In addition, each module includes concise summaries of key clinical data and implications of those data for clinical practice.
    Date Posted: 3/2/2017
  • Tailored for primary care clinicians, this program explores best practices on screening appropriate patients for HCV, evaluating HCV-infected patients, counseling patients on treatment, and understanding when to refer patients to a specialist.

    Hepatitis C Update: A Growing Challenge With Evolving Management Solutions

    Tailored for primary care clinicians, this program explores best practices on screening appropriate patients for HCV, evaluating HCV-infected patients, counseling patients on treatment, and understanding when to refer patients to a specialist.
    Date Posted: 2/21/2017
  • Jordan J. Feld, MD, MPH, illustrates the key data on optimal management of fibrosis and cirrhosis in HBV, including the effect of therapy on fibrosis/cirrhosis regression and HCC and applying the data to clinical practice.

    The Impact of HBV Therapy on Fibrosis and Cirrhosis

    Jordan J. Feld, MD, MPH, illustrates the key data on optimal management of fibrosis and cirrhosis in HBV, including the effect of therapy on fibrosis/cirrhosis regression and HCC and applying the data to clinical practice.
    Date Posted: 12/22/2016
  • In this program, expert faculty review strategies for eliminating HCV infection, both at the individual level and at the population level. An online video module and a downloadable slideset provide an overview of where the HCV field now stands, from the unprecedented levels of efficacy and simplicity in curing individual patients to the steps required to advance toward the goal of eradicating HCV across communities and ultimately throughout the world.

    HCV: Continuing Advances From Individual Cure to Disease Elimination

    In this program, expert faculty review strategies for eliminating HCV infection, both at the individual level and at the population level. An online video module and a downloadable slideset provide an overview of where the HCV field now stands, from the unprecedented levels of efficacy and simplicity in curing individual patients to the steps required to advance toward the goal of eradicating HCV across communities and ultimately throughout the world.
    Date Posted: 12/7/2016
10 of 48 Shown
Show 10 More
Loading...